NEW YORK (GenomeWeb News) – What has surprised Chris Austin most as he has begun settling into his new job as director of the National Center for Advancing Translational Sciences has been the volume of eager responses the new center has received from people across the biomedical science spectrum.

He has spent much of his time answering emails and calls from "high level people in every arena of the research ecosystem" who want to know what programs NCATS has in the works and how they may be able to get involved.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.

The New York Times' George Johnson muses on cancer's roots in multicellularity.